The results of the present work are consistent with the earlier report by Ramalingam et al. who demonstrated that NRs induce MNK degradation and block eIF4E phosphorylation in triple negative and Her2-overexpressing breast cancers. Here, ERBB2 is linked to breast carcinoma.